Abbott's $25B Acquisition of St. Jude Medical Will Not Impact Alere Buy | GenomeWeb

NEW YORK (GenomeWeb) — Abbott said today that its deal to acquire St. Jude Medical for $25 billion in cash and stock does not conflict with its previously announced acquisition to buy Alere, and that its financing plan contemplates the completion of both transactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.